Skip to content

Clinical trials

Phase 1 Anemia, Hemolytic, Autoimmune trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Anemia, Hemolytic, Autoimmune Phase: Phase 1 Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20211
20231
20244
20255
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Not yet recruiting4
Completed2
Unknown status2
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China6
China Immunotech (Beijing) Biotechnology Co., Ltd.2
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology2
Beijing Boren Hospital1
Changzhou No.2 People's Hospital1
Circunited BioPharma (Shenzhen) Co., Ltd.1
CytoCares Inc1
Grit Biotechnology1
Juventas Cell Therapy Ltd.1
Zhejiang University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Anemia, Hemolytic, Autoimmune17
Lupus Erythematosus, Systemic5
Myositis3
Scleroderma, Systemic3
Recurrence2
Amyloidosis1
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis1
Arthritis, Rheumatoid1
Autoimmune Diseases1
Burkitt Lymphoma1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.